Back to search

Article

Allele-specific gene editing approach for vision loss restoration in <i>RHO</i> -associated Retinitis Pigmentosa

2022-11-16

Abstract excerpt

Mutant RHO is the most frequent genetic cause of autosomal dominant retinitis pigmentosa. Here, we developed an allele-specific gene editing therapeutic drug to selectively target the human T17M RHO mutant allele while leaving the wild-type RHO allele intact for the first time. We identified a Staphylococcus aureus Cas9 (SaCas9) guide RNA that was highly active and specific to the human T17M RHO allele. In v...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7c89a591-438a-5c60-b873-70b68ea0770e
DOI
10.1101/2022.11.16.516784
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Allele-specific gene editing approach for vision loss restoration in <i>RHO</i> -associated Retinitis PigmentosaDOI 10.1101/2022.11.16.516784
Select a neighboring publication to make it the new centre.